Fig. 1From: Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective studyChanges in the treatment and surveillance paradigms for oesophageal, GOJ and gastric adenocarcinomas. CF = cisplatin and 5-fluorouracil, ECF/X = epirubicin, cisplatin and 5-fluorouracil/capecitabineBack to article page